ICU Drug Dilutions for Infusion
Vasopressors and Inotropes
Norepinephrine should be initiated as the first-choice vasopressor to maintain MAP ≥65 mmHg in septic shock, with standard dilution of 4-16 mg in 250 mL (16-64 mcg/mL) administered via central line. 1
Norepinephrine
- Standard concentration: 16-64 mcg/mL (4-16 mg in 250 mL D5W or NS) 1
- Initial infusion rate: 0.05-0.1 mcg/kg/min, titrate to MAP ≥65 mmHg 1
- Administration: Requires central venous access for optimal safety; peripheral administration acceptable temporarily during resuscitation 2
Epinephrine
- Standard concentration: 16-64 mcg/mL (4-16 mg in 250 mL D5W or NS) 2
- Dosing: 0.05-0.5 mcg/kg/min for cold shock with low blood pressure in pediatrics; consider as second-line agent in adults 2
- Indication: Cold shock unresponsive to dopamine, or as additional agent when norepinephrine alone insufficient 2, 1
Dopamine
- Standard concentration: 1600-3200 mcg/mL (400-800 mg in 250 mL D5W or NS) 2
- Dosing range: 5-20 mcg/kg/min 2
- Note: Reserved for highly selected patients (low risk of tachyarrhythmias, absolute/relative bradycardia) 1
Vasopressin
- Standard concentration: 0.4-1 unit/mL (20-40 units in 50-100 mL NS or D5W) 2
- Dosing: 0.03-0.04 units/min (fixed dose, not titrated) 2
- Use: Warm shock with persistent hypotension despite norepinephrine 2
Neuromuscular Blocking Agents
Cisatracurium should be diluted to 0.1 mg/mL (10 mg/100 mL) or 0.4 mg/mL (40 mg/100 mL) in D5W, NS, or D5NS for continuous infusion in mechanically ventilated ARDS patients. 3
Cisatracurium
- Standard dilutions: 0.1 mg/mL or 0.4 mg/mL 3
- Compatible diluents: 5% Dextrose, 0.9% Sodium Chloride, or 5% Dextrose/0.9% Sodium Chloride 3
- Initial infusion rate: 3 mcg/kg/min to counteract spontaneous recovery, then 1-2 mcg/kg/min for maintenance 3
- Reduction required: Decrease infusion rate by 30-40% during isoflurane or enflurane anesthesia 3
- Stability: Diluted solutions stable for 24 hours refrigerated or at room temperature 3
- Indication: Recommended for ≤48 hours in sepsis-induced ARDS with PaO2/FiO2 <150 mmHg 2
Infusion Rate Tables for Cisatracurium (0.1 mg/mL concentration)
Sedation
Minimize continuous sedation in mechanically ventilated sepsis patients, targeting specific endpoints rather than deep sedation. 2
General Principles
- Strategy: Use intermittent boluses preferentially over continuous infusions 2
- Protocolized approach: Daily sedation interruption or systematic titration to predefined endpoints reduces mechanical ventilation duration 2
- Avoid: Deep sedation associated with prolonged ICU stay 2
Tranexamic Acid
For major trauma with mild-to-moderate TBI, administer 1 g IV over 10 minutes within 3 hours of injury, followed by 1 g over 8 hours, OR 2 g IV over 20 minutes as single bolus. 2
Trauma Dosing
- Loading dose: 1 g IV over 10 minutes within 3 hours of injury 2
- Maintenance: 1 g IV over 8 hours 2
- Alternative: 2 g IV over 20 minutes as single bolus within 3 hours 2
Postpartum Hemorrhage
- Initial dose: 1 g IV over 10 minutes within 3 hours of bleeding onset 2
- Repeat dose: 1 g IV if bleeding continues after 30 minutes or restarts within 24 hours 2
Hydrocortisone
Administer IV hydrocortisone 200 mg per day only if adequate fluid resuscitation and vasopressor therapy fail to restore hemodynamic stability in septic shock. 2
- Dose: 200 mg/day IV (typically divided as 50 mg IV every 6 hours) 2
- Indication: Refractory septic shock unresponsive to fluids and vasopressors 2
- Pediatric consideration: Use in patients at risk for absolute adrenal insufficiency 2
Antibiotics - Empirical Sepsis Coverage
Administer broad-spectrum IV antibiotics within 1 hour of recognizing sepsis or septic shock. 1
First-Line Regimens
- Piperacillin/tazobactam: 4.5 g IV every 6-8 hours 4
- Ceftriaxone: 2 g IV daily for sepsis 4
- Cefepime: 2 g IV every 8-12 hours 4
Combination Therapy
- Add gentamicin: 5-7 mg/kg IV daily (once-daily dosing) to cephalosporins initially, de-escalate after 48-72 hours 4
Fluid Resuscitation
Administer at least 30 mL/kg IV crystalloid rapidly within first 3 hours for sepsis-induced hypoperfusion, using 20 mL/kg boluses over 5-10 minutes in pediatrics. 1, 2
Adult Dosing
- Initial bolus: 30 mL/kg IV crystalloid within 3 hours 1
- Target: MAP ≥65 mmHg, urine output ≥0.5 mL/kg/hr, lactate normalization 1
Pediatric Dosing
- Bolus size: 20 mL/kg isotonic crystalloid or albumin over 5-10 minutes 2
- Repeat: Up to 60 mL/kg total until perfusion improves or hepatomegaly/rales develop 2
- Switch to inotropes: If hepatomegaly or rales present, do not continue fluid boluses 2
ARDS Patients
- Conservative strategy: Minimize fluid infusion targeting CVP <4 mmHg or PAWP <8 mmHg once shock resolved 2
- Rationale: Reduces mechanical ventilation days and ICU length of stay without increasing renal failure 2
Blood Products
Transfuse RBCs only when hemoglobin decreases to <7.0 g/dL in adults with sepsis, targeting 7-9 g/dL, unless myocardial ischemia, severe hypoxemia, or acute hemorrhage present. 2, 1
RBC Transfusion
- Threshold: Hemoglobin <7.0 g/dL 2
- Target range: 7-9 g/dL 1
- Exceptions: Active myocardial ischemia, severe hypoxemia, acute hemorrhage 2
- Pediatric threshold: Hemoglobin <7.0 g/dL; target >10 g/dL in septic shock if ScvO2 <70% 2
Platelet Transfusion
- Prophylactic threshold: <10,000/mm³ without bleeding 2
- With bleeding risk: <20,000/mm³ 2
- Active bleeding/procedures: ≥50,000/mm³ 2
Drug Compatibility Considerations
Cisatracurium is incompatible with propofol and ketorolac for Y-site administration; use separate IV lines. 3
Compatible Solutions
- Cisatracurium compatible with: D5W, NS, D5NS, sufentanil, alfentanil, fentanyl, midazolam, droperidol 3
- Cisatracurium incompatible with: Propofol, ketorolac 3
pH Considerations
- Cisatracurium pH: 3.25-3.65 (acidic); incompatible with alkaline solutions pH >8.5 (e.g., barbiturates) 3
- Standardization principle: Group drugs by pH, medical indication, and chemical structure to minimize incompatibility 5
Common Pitfalls to Avoid
- Do not delay antibiotics beyond 1 hour while obtaining cultures 1
- Do not use β-agonists routinely in sepsis-induced ARDS without bronchospasm (increased mortality) 2
- Do not attempt to normalize blood pressure during active hemorrhage; accept lower MAP with volume resuscitation alone 2
- Do not continue aggressive fluid resuscitation in ARDS patients once shock resolved; switch to conservative strategy 2
- Do not use pulmonary artery catheters routinely in sepsis-induced ARDS 2
- Do not mix incompatible drugs through same IV lumen; standardize drug groupings by compatibility 5